The Landscape of Cardiovascular Clinical Trials in the United States Initiated Before and During COVID‐19
Year: 2020
Type: article
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,750
Funders: U.S. Department of Veterans Affairs, American Heart Association, Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Cleveland Clinic, CSL Behring, Boston Scientific Corporation, Boston VA Research Institute, Regeneron Pharmaceuticals, Ironwood Pharmaceuticals, Incorporated, Amarin Corporation, Medicines Company, MyoKardia, Regado Biosciences, Belvoir Media Group, Moderna, Eisai, Novo Nordisk, Idorsia Pharmaceuticals, St. Jude Medical, National Heart, Lung, and Blood Institute, Duke Clinical Research Institute, Daiichi Sankyo Europe
OpenAlex ID: W3045815594